We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is encouraging pharmaceutical manufacturers to use email and other forms of electronic communications, such as fax or text messaging, to announce voluntary recalls of FDA-regulated products or convey other important drug safety information to the public.
IVAX Pharmaceuticals has issued a national recall for its Goldline brand 500 mg Extra Strength Genapap (acetaminophen) and Extra Strength Genabs (acetaminophen) tablets and caplets due to a labeling error.
IVAX Pharmaceuticals has issued a national recall for its Goldline brand 500 mg Extra Strength Genapap (acetaminophen) and Extra Strength Genabs (acetaminophen) tablets and caplets due to a labeling error.